Platform
the platform
Our flexible platform provides researchers large, targeted data sets
Efferent’s Living Informatics combines cutting edge technologies and materials with high powered computing to collect and analyze in vivo data that provides never before available insight into cellular function and activity.
The ability for the CytoComm® platform to be easily tailored to the target of interest provides a valuable tool in preclinical research.
As a result, researchers and drug developers can make timely, informed decisions about which compounds have a greater probability of success and then accelerate development of those compounds, while significantly reducing R&D costs.
Play Video
HOW IT WORKS
CytoComm™ Living Biosensor
- Biosensor with living cells is inserted subcutaneously into laboratory animal
- Levels of biomarkers, proteins, medications, etc. are measured in the cells
- Data is wirelessly sent to the “cloud” where it is analyzed and securely accessible anytime, from anywhere
HOW IT WORKS
CytoComm® Living Biosensor
- Biosensor with living cells is inserted subcutaneously into laboratory animal
- Levels of biomarkers, proteins, medications, etc. are measured in the cells
- Data is wirelessly sent to the “cloud” where it is analyzed and securely accessible anytime, from anywhere
The Benefits
Data to researchers
More Data, More Often
CytoComm® is designed to provide a wealth of targeted data to researchers
Critical information when it happens
Researchers can gather critical information in real-time, allowing for preemptive action
Information available where you are
Gather vital information from anywhere, not only in the office or laboratory
Observation
Fluorescence from CytoComm® system
- Fluorescence from CytoComm® system observable when system challenged to increase inflammation markers
- Increase in fluorescence proportional to inflammation marker increase
- Animals tolerate the implantation of the bio chamber
- Improved cell viability when cells given 24 hr in bio chamber before implantation; good viability out to 21 days; cells respond too TNF-a for 21 days
Our transformative technology platform will dramatically reduce R&D costs.